Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

J. Motzer, Robert; Jonasch, Eric; Agarwal, Neeraj; Alva, Ajjai; J. Baine, Michael; E. Beckermann, Kathryn; I. Carlo, Maria; K. Choueiri, Toni; A. Costello, Brian; Derweesh, Ithaar; Desai, Arpita; Ged, Yasser; George, Saby; L. Gore, John; B. Haas, Naomi; Hancock, Steven; Kapur, Payal; E. Kyriakopoulos, Christos; T. Lam, Elaine; N. Lara, Primo; Lau, Clayton; Lewis, Bryan; C. Madoff, David; J. Manley, Brandon; Dror Michaelson, M.; Mortazavi, Amir; Nandagopal, Lakshminarayanan; R. Plimack, Elizabeth; Ponsky, Lee; Ramalingam, Sundhar; Shuch, Brian; L. Smith, Zachary; A. Sosman, Jeffrey; A. Dwyer, Mary; A. Gurski, Lisa; D. Motter, Angela

doi:10.6004/jnccn.2022.0001

Public

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • Jan 1, 2022

Authors:

Robert J. Motzer

Eric Jonasch

Neeraj Agarwal

Abstract

The NCCN Guidelines for Kidney Cancer focus on the screening, diagnosis, staging, treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage IV RCC typically undergo surgery and/or receive systemic therapy. Tumor histology and risk stratification of patients is importan...

Subject

Medicine

Kidney cancer

Systemic therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!